Skip to content
Research Article Open access CC BY 4.0

The Role of Alpha-Lactalbumin with Myoinositol in the Treatment of PCOS: A Review

Manish R. Pandya, Jignesh Shah, Varsha Narayanan

Asian Research Journal of Gynaecology and Obstetrics · pp. 256–262 · Published 10 Dec 2022

Abstract

Polycystic Ovary Syndrome (PCOS) presents commonly in women of reproductive age group, and has a multifactorial pathogenesis involving insulin resistance and androgen excess, influenced by obesity, diet, lifestyle, metabolic factors, stress, and environmental factors. Inositols (myoinositol-MI, D-chiro inositol-DCI) are part of the therapy options to address insulin resistance in PCOS. However, many women may be inositol nonresponsive due to competitive reduction of inositol intestinal absorption, gut dysbiosis and chronic inflammation. Addition of alpha-lactalbumin can help increase intestinal absorption of inositols, as well as improve gut dysbiosis and inflammation, along with reducing insulin resistance. Presented here is a review of studies that have shown improved rates of ovulation, MI absorption and levels, as well as metabolic and hormonal parameters, when alpha-lactalbumin is added to myoinositol.

PCOS myoinositol insulin resistance alpha-lactalbumin inositol resistance

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.